Treg-Therapy Allows Mixed Chimerism and Transplantation Tolerance Without Cytoreductive Conditioning

por Pilat, N, Baranyi, U, Klaus, C, Jaeckel, E, Mpofu, N, Wrba, F, Golshayan, D, Muehlbacher, F, Wekerle, T
Publicado 2010

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma

por Schmidinger, M, Wenzel, C, Locker, G J, Muehlbacher, F, Steininger, R, Gnant, M, Crevenna, R, Budinsky, A C
Publicado 2001

Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant

por Florman, S., Becker, T., Bresnahan, B., Chevaile‐Ramos, A., Carvalho, D., Grannas, G., Muehlbacher, F., O'Connell, P. J., Meier‐Kriesche, H. U., Larsen, C. P.
Publicado 2016